# EDGAR Filing Document

**Accession Number:** 0001945896
**File Stem:** 0000919574-26-002620
**Filing Date:** 2026-5
**Character Count:** 15560
**Document Hash:** 2dbdb1efe38ca54cfc06dabaa85cf0c8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000919574-26-002620.hdr.sgml**: 20260504

**ACCESSION NUMBER**: 0000919574-26-002620

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260504

**DATE AS OF CHANGE**: 20260504

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Eloxx Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001035354
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 841368850
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-56243
- **FILM NUMBER:** 26939594

**BUSINESS ADDRESS:**
- **STREET 1:** P.O. BOX 274
- **CITY:** ARLINGTON
- **STATE:** MA
- **ZIP:** 02476
- **BUSINESS PHONE:** 781-577-5300

**MAIL ADDRESS:**
- **STREET 1:** P.O. BOX 274
- **CITY:** ARLINGTON
- **STATE:** MA
- **ZIP:** 02476

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sevion Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20140930

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SENESCO TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 19991006

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NAVA LEISURE USA INC
- **DATE OF NAME CHANGE:** 19970310
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Domicilium Real Estate Fund III LP
- **CENTRAL INDEX KEY:** 0001945896

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 215 EAST BAY ST, SUITE 203-E
- **CITY:** CHARLESTON
- **STATE:** SC
- **ZIP:** 29401
- **BUSINESS PHONE:** 800-308-5260

**MAIL ADDRESS:**
- **STREET 1:** 215 EAST BAY ST, SUITE 203-E
- **CITY:** CHARLESTON
- **STATE:** SC
- **ZIP:** 29401

## Ex-99

<u>Exhibit A</u>

<u>JOINT FILING AGREEMENT</u>

The undersigned agree that this Schedule 13G dated May 4, 2026 relating to the Common Stock, $0.01 par value, of Eloxx Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.

---

| |
|:---|
| &nbsp;&nbsp; DOMICILIUM REAL ESTATE FUND III LP<br>By: /s/ Daniel Simon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Daniel Simon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Member of its general partner |

---

---

| |
|:---|
| &nbsp;&nbsp; DOMICILIUM REAL ESTATE FUND III GP LLC<br>By: /s/ Daniel Simon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Daniel Simon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Member |

---

---

| |
|:---|
| &nbsp;&nbsp; DOMICILIUM CAPITAL PARTNERS LLC<br>By: /s/ Daniel Simon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Daniel Simon |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Member |

---

&nbsp;&nbsp; DANIEL SIMON<br>By: /s/ Daniel Simon<br>

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** Eloxx Pharmaceuticals, Inc.

**Title of Class of Securities:** Common Stock, $0.01 par value

**CUSIP Number:** —

**Date of Event Which Requires Filing of this Statement:** 04/27/2026

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Domicilium Real Estate Fund III LP | Names of Reporting Persons<br>Domicilium Real Estate Fund III LP |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1250000.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1250000.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1250000.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1250000.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>16.5% | Percent of Class Represented by Amount in Row (9)<br>16.5% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

---

| 1. | Names of Reporting Persons<br>Domicilium Real Estate Fund III GP LLC | Names of Reporting Persons<br>Domicilium Real Estate Fund III GP LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1250000.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1250000.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1250000.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1250000.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>16.5% | Percent of Class Represented by Amount in Row (9)<br>16.5% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

---

| 1. | Names of Reporting Persons<br>Domicilium Capital Partners LLC | Names of Reporting Persons<br>Domicilium Capital Partners LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1407138.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1407138.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1407138.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1407138.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>18.6% | Percent of Class Represented by Amount in Row (9)<br>18.6% |
| 12. | Type of Reporting Person (See Instructions)<br>IA, OO | Type of Reporting Person (See Instructions)<br>IA, OO |

---

| 1. | Names of Reporting Persons<br>Daniel Simon | Names of Reporting Persons<br>Daniel Simon |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1407138.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1407138.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1407138.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1407138.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>18.6% | Percent of Class Represented by Amount in Row (9)<br>18.6% |
| 12. | Type of Reporting Person (See Instructions)<br>HC, IN | Type of Reporting Person (See Instructions)<br>HC, IN |

---

**Item 1(a). Name of Issuer:**
Eloxx Pharmaceuticals, Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
P.O. Box 274, 10 Court Street, Arlington, MA 02476

**Item 2(a). Name of Person Filing:**
Domicilium Real Estate Fund III LP
Domicilium Real Estate Fund III GP LLC
Domicilium Capital Partners LLC
Daniel Simon

**Item 2(b). Address of Principal Business Office:**
Domicilium Real Estate Fund III LP
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092

Domicilium Real Estate Fund III GP LLC
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092

Domicilium Capital Partners LLC
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092

Daniel Simon
535 S. Kimball Ave, Suite 140
Southlake, Texas 76092

**Item 2(c). Citizenship:**
Domicilium Real Estate Fund III LP - Delaware
Domicilium Real Estate Fund III GP LLC - Delaware
Domicilium Capital Partners LLC - Delaware
Daniel Simon - United States

**Item 2(d). Title of Class of Securities:**
Common Stock, $0.01 par value

**Item 2(e). CUSIP Number:**
—

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

Domicilium Real Estate Fund III LP - 1,250,000
Domicilium Real Estate Fund III GP LLC - 1,250,000
Domicilium Capital Partners LLC - 1,407,138
Daniel Simon - 1,407,138

**(b) Percent of class:**

Domicilium Real Estate Fund III LP - 16.5%
Domicilium Real Estate Fund III GP LLC - 16.5%
Domicilium Capital Partners LLC - 18.6%
Daniel Simon - 18.6%

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

Domicilium Real Estate Fund III LP - 0
Domicilium Real Estate Fund III GP LLC - 0
Domicilium Capital Partners LLC - 0
Daniel Simon - 0

**(ii) Shared power to vote or to direct the vote:**

Domicilium Real Estate Fund III LP - 1,250,000
Domicilium Real Estate Fund III GP LLC - 1,250,000
Domicilium Capital Partners LLC - 1,407,138
Daniel Simon - 1,407,138

**(iii) Sole power to dispose or to direct the disposition of:**

Domicilium Real Estate Fund III LP - 0
Domicilium Real Estate Fund III GP LLC - 0
Domicilium Capital Partners LLC - 0
Daniel Simon - 0

**(iv) Shared power to dispose or to direct the disposition of:**

Domicilium Real Estate Fund III LP - 1,250,000
Domicilium Real Estate Fund III GP LLC - 1,250,000
Domicilium Capital Partners LLC - 1,407,138
Daniel Simon - 1,407,138

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

All of the securities reported in this Schedule 13G are directly owned by advisory clients of Domicilium Capital Partners LLC. None of those advisory clients, other than Domicilium Real Estate Fund III LP, may be deemed to beneficially own more than 5% of the Common Stock, $0.01 par value.

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Domicilium Real Estate Fund III LP**

**Date:** 05/04/2026

**By:** /s/ Daniel Simon

**Name & Title:** Daniel Simon, Managing Member of its general partner

**Domicilium Real Estate Fund III GP LLC**

**Date:** 05/04/2026

**By:** /s/ Daniel Simon

**Name & Title:** Daniel Simon, Managing Member

**Domicilium Capital Partners LLC**

**Date:** 05/04/2026

**By:** /s/ Daniel Simon

**Name & Title:** Daniel Simon, Managing Member

**Daniel Simon**

**Date:** 05/04/2026

**By:** /s/ Daniel Simon

**Name & Title:** Daniel Simon